Philipp Keller, CFO
Professional Overview
Philipp Keller is an experienced finance executive with a strong background in the healthcare industry. As the Chief Financial Officer at Patient21, he is responsible for overseeing the company's financial strategy, operations, and long-term growth initiatives.
Experience Summary
Current Role
Philipp has served as the CFO of Patient21, a leading healthcare technology company, since October 2020. In this role, he is responsible for managing the company's financial resources, optimizing operational efficiency, and supporting strategic decision-making. Under his financial leadership, Patient21 has achieved significant milestones, including securing new funding rounds and expanding its market presence.
Career Progression
Prior to his current position, Philipp co-founded and served as the CEO of Tail, a successful healthcare technology startup, from 2016 to 2020. In this role, he played a pivotal part in the company's growth and eventual acquisition. Before his entrepreneurial endeavors, Philipp held positions in the investment banking sector, including as an Executive Director in the Healthcare Investment Banking division at Morgan Stanley and an Associate at Deutsche Bank. He began his career as an Analyst at EY, where he gained valuable experience in financial analysis and consulting.
Academic Background
Philipp holds a Bachelor's degree in Business Administration from a leading university in Germany, where he specialized in finance and accounting.
Areas of Expertise
Philipp's areas of expertise include financial management, strategic planning, mergers and acquisitions, and healthcare technology. He has a proven track record of driving financial performance, implementing cost-saving measures, and securing funding to support organizational growth. Additionally, Philipp's extensive experience in the healthcare industry allows him to provide valuable insights and strategic guidance to his clients and stakeholders.
Professional Impact
Throughout his career, Philipp has demonstrated a strong commitment to professional excellence and industry leadership. As the co-founder and CEO of Tail, he successfully navigated the company through a period of rapid growth and eventual acquisition, generating significant returns for investors. In his current role as CFO of Patient21, Philipp has been instrumental in securing new funding rounds and expanding the company's market presence, contributing to its overall success and industry impact.
Conclusion
Philipp Keller is a seasoned finance executive with a diverse background in the healthcare industry. His combination of financial expertise, strategic vision, and industry knowledge makes him a valuable asset to Patient21 and a respected leader in the field. As he continues to drive the company's financial strategy and support its growth initiatives, Philipp is poised to make a lasting impact on the healthcare technology landscape.